Drug Shortage Report for METHOTREXATE SUBCUTANEOUS

Last updated on 2023-06-30 History
Report ID 175814
Drug Identification Number 02491338
Brand name METHOTREXATE SUBCUTANEOUS
Common or Proper name METHOTREXATE SODIUM
Company Name ACCORD HEALTHCARE INC
Market Status MARKETED
Active Ingredient(s) METHOTREXATE
Strength(s) 17.5MG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 1
ATC code L04AX
ATC description IMMUNOSUPPRESSANTS
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date
Actual start date 2022-11-26
Estimated end date 2023-06-29
Actual end date 2023-06-29
Shortage status Resolved
Updated date 2023-06-30
Company comments
Health Canada comments
Tier 3 Status No
Company contact information Customer Service at (514) 505-4159 ext. 203 | Service à la clientèle à (514) 505-4159 poste 203

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v31 2023-06-30 French Compare
v30 2023-06-30 English Compare
v29 2023-06-23 French Compare
v28 2023-06-23 English Compare
v27 2023-06-12 French Compare
v26 2023-06-12 English Compare
v25 2023-05-19 French Compare
v24 2023-05-19 English Compare
v23 2023-05-05 French Compare
v22 2023-05-05 English Compare
v21 2023-05-05 French Compare
v20 2023-05-05 English Compare
v19 2023-04-15 French Compare
v18 2023-04-15 English Compare
v17 2023-03-22 French Compare
v16 2023-03-22 English Compare
v15 2023-03-20 French Compare
v14 2023-03-20 English Compare
v13 2023-03-06 French Compare
v12 2023-03-06 English Compare

Showing 1 to 20 of 31